COVID-19 has had a significant impact on some of the most vulnerable and vulnerable people in the world, including those of color, health and economic well-being. Ensuring that the COVID-19 vaccine in these areas is available can help alleviate the virus and protect the herd. Biden’s management has recognized the importance of the vaccine, but localities and regions vary according to their need for similar importance. Since the vaccine released in the US is natural, an understanding of how vaccines change locally is essential for informing efforts and addressing justice. Early CDC analysis found that, from the beginning of March, the most vulnerable populations had the lowest immunization coverage than the most undeveloped regions.
This journal continues its review of research into how vaccines vary so far in governments and identifies key indicators related to high or low vaccines. Based on KFF analysis of data from the Centers for Disease Control and Prevention (CDC) which shows that the percentage of people with complete immunization in the state; This date also covers this section for those 65 years of age or older. Much of the CDC’s data, although incomplete (see method), provides sufficient information for vaccine research in the County. The result of this brief use is May 11, 2021 and includes 77% of all shares (2,415) in the US. See the Process Box for more details, what is included in the review, and the process.
There are significant differences in vaccine prices throughout the US (Figure 1). In all 2,415 areas included in this study, the average vaccine between the rich and the poor is 33.6% of the total population. About one third of all vaccines received or more of the vaccine, while 1% of all governments received 50% or more of the vaccine.
There are also mixed results on how the vaccine is related to global attitudes and prioritization decisions. CDC encouraged so long as the vaccine is in short supply, other groups will have access to the first vaccine, including long-term health care workers, as well as the elderly and medical professionals who are at high risk of COVID-19. While all countries are now expanding the eligibility of anyone 16 years or older, initially, they gives vaccines to the elderly in advance in addition to health workers and long-term caregivers. Among other things, due to early planning for the elderly and high immunization of the elderly, districts with a higher percentage of people aged 65 or older have a higher vaccination rate (31.4%) than those with a lower percentage of people aged 65 or older. above (29.8%). In contrast, most countries it was quick to open up opportunities for those with medical risks and the list of appropriate values varied across countries. We found that regions with higher rates of people with other medical conditions had lower immunization rates, compared with those with lower prevalence (25.5% vs. 33.9%).
In addition, the vaccine did not appear to be linked to COVID-19. Importantly, the regions with the highest levels of COVID-19 transmission are more vaccinated than those with low levels of transmission. The CDC reports the number of district distributions in the districts based on the cases of 100,000 people and the well-tested divisions last week. Governments that are known to have “high levels” of community policing (thus having more demonstrations and lower exams) have an average immunization rate of 30.5% compared to 27.2% of states with a “low” population prevalence. Because of the large number of allocations that reflect current cases and the quality of testing, residents with high levels of government may be encouraged to get vaccinated. It may be that the prevalence of COVID-19 is currently concentrated in areas with more vaccines due to other factors. At the same time, areas with the highest mortality rates and the deaths of 100,000 people are less likely to be vaccinated than those with lower mortality rates and mortality. In states with the highest number of cases and 100,000 deaths, vaccination rates were 29.1% and 28.3%, as opposed to 31.8% and 32.1%, respectively in cities with the lowest mortality rates and 100,000 deaths.
Uninsured prices and poor areas are associated with a decrease in vaccination. The prevalence of immunization in low-cost states is 25.8% compared to 33.9% in low-cost uninsured states. Increased poverty, which is associated with a lack of insurance and can lead to other barriers to getting vaccinated, is also aided by a smaller vaccine.
In line with the recent CDC research, the sections at the top of the Social Vulnerability Index (SVI) (at high risk) have a lower immunization rate than the lower levels in the list (25.8% vs. 32.5%). This is not surprising because SVI includes economic, age, race / ethnicity categories, some of which are discussed above, as well as other disability options, housing, and transportation. However, the high-risk components currently have less vaccination than the low-risk components.
Metro governments have more population immunizations than non-metro towns, and vaccination rates are lower in the states that voted for Trump compared to those that voted for Biden. The proportion of all people who received the vaccine in metro districts is 31.3% compared to 28.7% in non-metro towns. In addition, related evidence of delayed vaccination among Republican voters, the number of vaccines in the states that voted for Trump in the 2020 elections is 28.5% compared to 35.0% in the states that voted for Biden.
This cross-sectional vaccine review provides further evidence that COVID-19 vaccine is still incomplete. Areas with the highest proportion of people affected by COVID-19, including those with medical risks, as well as those living in poverty, have a lower immunization rate than areas with the lowest proportion of the population. In addition, areas that are at high risk for human habitation have a lower immunization rate with lower SVI. This can be used to help improve the work of vaccination and vaccination. In addition, we find that the COVID-19 virus-carrying regions have high levels of vaccines, indicating that these communities are responding to developments in their area and are trying to vaccinate and prevent rising cases in some areas that seem to be working.
|This magazine gives a brief overview of government policy and reviews.
Our main results, the vaccine and County benefits, were taken from the Centers for Disease Control and Prevention’s (CDC) Integration of COVID-19 County. CDC reports finalize the general vaccine for people over the age of 65. Most are unknown in Hawaii, New Mexico, Texas, and smaller counties in Alaska and California. In addition, we remove urban data in which less than 80% of vaccines cover a residential area, which removed information from Colorado, Georgia, Vermont, Virginia, and West Virginia. The survey covers data from 2,415 towns, 77% of all governments (3,142) in the US.
The prevalence of high-prevalence vaccines in the general population is low compared to national statistics due to a lack of data from governments and several regions as described above.
We also apply the CDC’s definition of “community outreach”, which divides into sections based on new cases per 100,000 population as well as a portion of quality tests in the last 7 days.
Most subdivisions and populations are excluded from Census Bureau’s The 2019 American Community Survey 5-year survey by County. We use ACS information to categorize it according to age of residence, race / ethnicity, poverty, and health information. In particular, we count the proportion of people over the age of 65, people of color, non-Spanish Blacks, Hispanics, low-income families in poverty, and no insurance.
Details of the cases and deaths were taken on May 11, 2021 from Johns Hopkins University County data. In the case of 100,000 cases / deaths, the statistics for each region were removed from the Census Bureau’s database – using the general population.
The results of the 2020 Presidential Election were removed from a GitHub repository which wrote extensively from publications such as The Guardian, townhall.com, Fox News, Politico, and the New York Times. Alaska is no longer included in the region in the survey because it is the only one that exists in the state and cannot run in the cities.
Metro and non-metro parts come from the US department of Agriculture Rural-Urban Continuum Messages 2013. Areas with numbers 1 to 3 are known as “metro” and 4 to 9 are known as “non-metro.”
Most of the population with medical conditions that put them at high risk for serious COVID-19 and County issues came from CDC. These included kidney disease, COPD, heart disease, diabetes, and obesity (BMI> = 30).
The County Social Vulnerability Index (SVI) is derived from the CDC’s Agency for Registry Substances and Diseases. SVI highlights community insecurity based on other cultural factors (e.g., socioeconomic status, family structure, language, etc.) that may affect the community in the event of a disaster.
To divide the sections, we interpret all the methods differently, using the category definition below:
Given the current concerns about access to COVID-19 vaccine, a review of vaccine differences by race / ethnicity in governments could increase existing countries data rate. However, the results of our analysis are inaccurate compared to self-reported studies showing that people of Spanish descent have a lower immunization rate than whites, which leads us to believe that there are compelling reasons behind these ethnicities and ethnicities. As a result, we do not include comparisons based on race and ethnicity.
Disclaimer: The opinions expressed within this article are the personal opinions of the author. The facts and opinions appearing in the article do not reflect the views of knews.uk and knews.uk does not assume any responsibility or liability for the same.